Directory Image
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.

Gene Editing Market projected To Grow With Significant CAGR Over The Forecast Period

Author: Ram Reddy
by Ram Reddy
Posted: May 22, 2018

Gene Editing Market projected To Grow With Significant CAGR Over The Forecast Period

Global Gene Editing Market: Gene editing or Genome editing is the type of genetic editing where DNA is inserted, replaced or deleted in the genome of an organism in order to treat a specific disease by using a molecular scissors or engineered nuclease. These nucleases create site-specific double-stranded breaks in desired locations in genome. The induced double-stranded breaks are repaired through non-homologous end joining or homologous recombination resulting in targeted mutations (edits).

Rise in the prevalence in rate of cancer & other genetic disorders, increasing preference in the personalized medicine, companies investments towards R&D, and growth of biotechnology and pharmaceutical industries, increase in private and public sector funding, rapid advancements in sequencing and gene editing technologies, applications in various drug discovery processes are some of the factors propelling the growth of the genome editing market. However, global gene editing market is hindered by stringent government regulations to approve gene mutation projects, ethical issues, unavailability of gene editing based therapeutics in the market and lack of awareness among people regarding the safety of genetic interventions.

Free sample of this report is available upon request @

The global gene editing market is categorized on the following topics-

1. Technology

  • Zinc Finger Nuclease (ZFN)
  • Clustered regularly interspaced short palindromic repeats (CRISPR)
  • Transcription activator-like effector nuclease (TALEN)
  • Others

2. Applications

  • Cell Line Editing
  • Targeted gene mutation
  • Animal Genome Editing
  • Plant Genome Editing

3. Product type

  • Consumables
  • Instruments and Software

4. End-users

  • Pharmaceutical companies
  • Biotechnology Companies
  • Academics
  • Clinical Research Organizations

Free TOC of this report is available upon request @

And lastly on the basis of geographical regions, the genome editing market is divided into five major regions- Europe, North America, Latin America, Asia Pacific, and the Middle East & Africa. North America dominates the gene editing market due to the strong growth trend in the pharmaceuticals and biotechnology industries. Emerging economies of Asia Pacific and Latin America are expected to show significant growth in the gene editing market. This is due to an increase in the number of laboratories in these regions and development of existing ones for automation of various instrumentation systems, the expansion of leading genome editing companies and increased R&D spending.

Some of the key players in genome editing market are Cellectis S.A. (France), Applied Stemcell, Inc. (U.S.), Genscript (U.S.), Merck KGaA (Germany), Horizon Discovery Group plc,(U.K.), Origene Technologies, Inc. (U.S.), System Biosciences, Inc. (U.S.), Sangamo Therapeutics, Inc.(U.S.), Thermo Fisher Scientific (U.S), and Transposagen Biopharmaceuticals, Inc.(U.S.) are some names. In 2017, Cellectis was granted the European Patent for the invention of the genetically engineering T-cells by adopting RNA-guided endonucleases, such as CRISPR associated protein 9 (Cas9) or Centromere and Promoter Factor 1(Cpf1 ). While in the same year, Sangamo Therapeutics, Inc. also received the U.S.FDA Fast Track designation for in-vivo genome editing product candidates SB-318 and SB-913 to treat Mucopolysaccharidosis Type I (MPS I) and MPS II. And in 2016, OriGene Technologies entered strategic agreement with EdiGene (Beijing, China) for the development of genome-wide knockout cells from laboratory cell lines.

Ask Analyst for Full Information about this report @

Biotechnology and pharmaceutical sectors dominate gene editing market due to its applications in drug discovery and therapeutics. Rise in usage of CRISPR and ZFN, companies are investing in innovative research for development of novel gene editing techniques. Many players are adopting various strategies which include collaborations for R&D outsourcing, mergers and acquisitions, strategic or manufacturing activities are propelling the growth of genome editing market. For example, in 2014, Thermo Fisher acquired Life Technologies, to create unbeatable leadership in life sciences, research, specialty diagnostics and applied markets. In 2014, Sigma-Aldrich Corporation (U.S.) entered into an agreement with Broad Institute of MIT and Harvard (U.S.) to use CRISPR technology. High growth potential in emerging regions provides lucrative opportunities to industry players.

Get access to full summary @

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX


Toll Free (US):+1-866-598-1553

Website @

About the Author

Website @

Rate this Article
Leave a Comment
Author Thumbnail
Please or Join to add a comment.
Author: Ram Reddy

Ram Reddy

Flag of United Kingdom
United Kingdom

Member since: May 02, 2018
Total live articles: 57

Related Articles